Dysregulated expression of microRNAs acts as prognostic and diagnostic biomarkers for glioma patients.
Yusrah MasoodManahil ShalMuhammad Furqan ShahMaria Fazal Ul HaqMahmmood Akhtar KayaniIshrat MahjabeenPublished in: Molecular genetics and genomics : MGG (2022)
Our results demonstrated significant deregulation of selected microRNAs in glioma patients. This deregulated expression was found associated with significant increased risk of glioma and could be further developed as effective prognostic biomarker and therapeutic tool in said disease.